Home › Funds › Boston Trust Walden Corp › CHE
Boston Trust Walden Corp position in CHE
CHEMED CORP NEW · Health Care
Boston Trust Walden Corp reported holding 191,501 shares of CHE (CHEMED CORP NEW) in its Q3 2026 13F filing — a position valued at US$96.7M, representing 0.78% of its reported portfolio and ranking #26 among its reported holdings. Boston Trust Walden Corp has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Boston Trust Walden Corp's CHE position evolved
Boston Trust Walden Corp first disclosed a stake in CHE in Q3 2023 at 216,337 shares (US$112.4M). The position peaked in Q1 2025 at 246,351 shares, worth US$151.6M. Across 13 filings, Boston Trust Walden Corp increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 191,501 shares valued at US$96.7M — a reduction of -9,774 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 216.34K | $112.43M | New |
| Q4 2023 | 199.15K | $116.45M | Reduce |
| Q1 2024 | 210.40K | $135.06M | Add |
| Q2 2024 | 221.44K | $120.15M | Add |
| Q3 2024 | 220.07K | $132.25M | Reduce |
| Q4 2024 | 242.17K | $128.30M | Add |
| Q1 2025 | 246.35K | $151.58M | Add |
| Q2 2025 | 247.43K | $120.48M | Hold |
| Q3 2025 | 234.47K | $104.98M | Reduce |
| Q4 2025 | 221.24K | $94.66M | Reduce |
| Q1 2026 | 205.20K | $77.51M | Reduce |
| Q2 2026 | 201.28K | $93.74M | Reduce |
| Q3 2026 | 191.50K | $96.72M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CHE and 13F data
CHE (CHEMED CORP NEW) is a Health Care company. 22 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.8M), River Road Asset Management, LLC (US$100.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CHE
- Epoch Investment Partners, Inc. 247.05K sh · $124.78M · Q3 2026
- River Road Asset Management, LLC 199.05K sh · $100.53M · Q3 2026
More on Boston Trust Walden Corp
FAQ
How long has Boston Trust Walden Corp held CHE?
Boston Trust Walden Corp has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Boston Trust Walden Corp's current position in CHE?
As of Q3 2026, Boston Trust Walden Corp holds 191.50K shares of CHE (CHEMED CORP NEW), valued at $96.72M, representing 0.78% of its reported portfolio and ranking #26.
Has Boston Trust Walden Corp been buying or selling CHE?
In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in CHE. The position peaked in Q1 2025 at 246.35K shares.
Which other funds hold CHE?
Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.